Authors: STEMPEL DA DURCANNINROBBINS JF HEDBLOM EC WOOLF R STURM LL STEMPEL AB

Citation: Da. Stempel et al., DRUG UTILIZATION EVALUATION IDENTIFIES COSTS ASSOCIATED WITH HIGH USEOF BETA-ADRENERGIC AGONISTS, Annals of allergy, asthma, & immunology, 76(2), 1996, pp. 153-158

Authors: STEMPEL DA HEDBLOM EC DURCANINROBBINS JF STURM LL

Citation: Da. Stempel et al., USE OF A PHARMACY AND MEDICAL CLAIMS DATABASE TO DOCUMENT COST CENTERS FOR 1993 ANNUAL ASTHMA EXPENDITURES, Archives of family medicine, 5(1), 1996, pp. 36-40

Authors: STEMPEL DA STURM LL HEDBLOM EC DURCANINROBBINS JF

Citation: Da. Stempel et al., TOTAL-COST OF ASTHMA CARE, Journal of allergy and clinical immunology, 95(1), 1995, pp. 217-217

Authors: STURM LL STEMPEL DA STEMPEL AB HEDBLOM EC DURCANINROBBINS JF

Citation: Ll. Sturm et al., DRUG UTILIZATION REVIEW (DUR) IDENTIFIES COSTS DUE TO OVERUSE OF INHALED BETA-AGONISTS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 223-223